Portfolio company
Teiko Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
Teiko Bio develops immune profiling platforms using mass cytometry to provide drug target discovery and biomarker analysis for biopharmaceutical companies and clinical researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Immunai
Immunai develops an immune system mapping platform for biopharmaceutical companies to discover and optimise drug targets and clinical trials.
IMU
IMU Biosciences develops an immune profiling platform using machine learning to provide diagnostic insights for clinicians, researchers and pharmaceutical companies.
Lightcast Bio
This company develops a microfluidic platform for single-cell functional analysis for pharmaceutical companies and academic research institutions.
Infinity Bio
This company provides antibody reactome profiling services using its molecular indexing platform for biopharmaceutical, academic and government researchers.
Tcubeit
This company develops T cell manufacturing platforms and immunotherapy pipelines for pharmaceutical firms and research institutions treating cancer and rare diseases.
Spectacell
This company develops a label-free single-cell analysis platform for pharmaceutical and biotechnology organisations to measure the performance of immune therapies.
Cytek
Cytek Biosciences manufactures cell analysis tools and flow cytometry systems for pharmaceutical companies, academic research institutions and contract research organisations.
Tesorai
Tesorai develops an artificial intelligence platform for mass spectrometry proteomics analysis serving biotechnology and pharmaceutical research teams.